Cargando…
Successful combination therapy of cyclosporine and methotrexate for refractory polymyositis with anti-Jo-1 antibody: a case report.
Although corticosteroids have been the initial agent for the treatment of inflammatory myopathies (IM), immunosuppressive agents such as azathioprine, methotrexate, cyclophosphamide, or cyclosporine are commonly required to control the disease except mild cases. On the other hand, the efficacy of co...
Autores principales: | Chang, Hyun Kyu, Lee, Deok Hee |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Korean Academy of Medical Sciences
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3054986/ https://www.ncbi.nlm.nih.gov/pubmed/12589104 |
Ejemplares similares
-
Serum levels of B-cell activating factor of the TNF family (BAFF) correlate with anti-Jo-1 autoantibodies levels and disease activity in patients with anti-Jo-1positive polymyositis and dermatomyositis
por: Kryštůfková, Olga, et al.
Publicado: (2018) -
Polymyositis-Dermatomyositis and Interstitial Lung Disease in Pregnant Woman Successfully Treated with Cyclosporine and Tapered Steroid Therapy
por: Mayu, Saito, et al.
Publicado: (2019) -
A Case of Refractory Polymyositis Successfully Treated With Abatacept Monotherapy
por: ÇAĞLAYAN, Mehmet, et al.
Publicado: (2020) -
Patients with anti-Jo1 antibodies display a characteristic IgG Fc-glycan profile which is further enhanced in anti-Jo1 autoantibodies
por: Fernandes-Cerqueira, Cátia, et al.
Publicado: (2018) -
Jo Coenen
Publicado: (1995)